- Global Pharma News & Resources

Global Insulin Syringes Market 2022-2026: Rising Rates of Diabetes Worldwide Driving 4.69% Growth -

DUBLIN--(BUSINESS WIRE)--The "Global Insulin Syringes Market 2022-2026" report has been added to's offering.

The insulin syringes market is poised to grow by $ 408.67 mn during 2022-2026, accelerating at a CAGR of 4.69% during the forecast period. The report on the insulin syringes market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, favorable government initiatives, and the availability of diabetes self-management education programs.

The insulin syringes market analysis includes type segment and geographic landscape.

The insulin syringes market is segmented as below:

By Type

  • Type 2 diabetes
  • Type 1 diabetes

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa

This study identifies the increase in awareness programs for diabetes as one of the prime reasons driving the insulin syringes market growth during the next few years. Also, rising strategic partnerships to boost sales of insulin syringes and increasing focus on smart insulin syringes will lead to sizable demand in the market.

The report on the insulin syringes market covers the following areas:

  • Insulin syringes market sizing
  • Insulin syringes market forecast
  • Insulin syringes market industry analysis

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Disease Type

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

Companies Mentioned

  • AdvaCare Pharma
  • ASP Healthcare Pty Ltd.
  • Avantor Inc.
  • B. Braun SE
  • Becton Dickinson and Co.
  • Cardinal Health Inc
  • CODAN Medizinische Gerate GmbH and Co KG
  • Gerresheimer AG
  • Inc.
  • Hi-Tech Medics Pvt Ltd.
  • Hindustan Syringes and Medical Devices Ltd.
  • LAC Healthcare Solutions
  • Nipro Corp.
  • Novo Nordisk AS
  • Poly Medicure Ltd.
  • Smiths Group Plc
  • Terumo Corp.
  • Thermo Fisher Scientific Inc.
  • UltiMed Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 07-Nov-2022